Small molecule

A small molecule is a small, chemically manufactured compound with a low molecule weight. Small molecule drugs help regulate a biological target such as an enzyme, channel or receptor to modify a disease process.

The large majority of drugs on the market today are small molecules and most are delivered orally. Small molecule drugs are part of what Syncona calls, the “First Wave” of technologies in healthcare and are dominated by large pharmaceutical companies.

Omass Therapeutics is an Oxford University spin-out backed by Syncona Ltd and Oxford Sciences Innovation that is harnessing high-resolution native mass spectrometry and other biophysical technologies to drive drug discovery in high definition for immunology and genetic disease.